DISCLOSURE OF POTENTIALLY RELEVANT ROLES & INTERESTS - RADIATION MEDICAL ADVISORY COMMITTEE

The Royal Commission has established a Radiation Medical Advisory Committee for the purpose of providing the Commission with medical expertise during the course of its inquiries.

The Committee provides assistance to the Commission by:

  • Providing advice on current research and knowledge on the health effects of radiation, and;
  • Reviewing, providing comments and assistance in interpreting medical evidence collected by the Commission.

Each member of the Committee and a brief description of his or her background is outlined below. Further, information is also available as to each member’s:

  • current employment, consulting or research activities which may be relevant to the Commission’s Terms of Reference (current potentially relevant activities);
  • employment, consulting or research activities carried out in the last five years which may be relevant to the Commission’s Terms of Reference (potentially relevant activities in the last five years); and interests, being direct pecuniary interests or interests arising by association with organisations or professional associations, which may be relevant to the Commission’s Terms of Reference (other potentially relevant interests). It does not include indirect pecuniary interests such as shares held by a superannuation fund in which the member has an account.
  • Professor Roger Allison - Executive Director, Cancer Care Services, Royal Brisbane and Women’s Hospital

    After gaining membership of the Royal College of Physicians in 1972, Professor Allison trained in radiation oncology and oncology at the Royal Infirmary and Western General Hospital in Edinburgh. He obtained the Fellowship of the Royal College of Radiologists and was appointed a lecturer in radiation oncology at the University of Edinburgh. Roger has held the position of Executive Director, Cancer Care Services at the Royal Brisbane and Women’s Hospital since 1993. His professional interests include breast cancer, thyroid cancer, paediatric radiation oncology, palliative medicine, soft-tissue sarcomas and urological cancer. Roger has been active in the Royal Australian and New Zealand College of Radiologists. He was the chief sensor for 10 years and completed a four year term as Dean of Faculty of Radiation Oncology. He is currently chair of the ARPANSA Radiation Health and Safety Advisory Committee and a member of ARPANSA’s Clinical Advisory Group.

    Current potentially relevant activities:

      • Chair, ARPANSA Radiation Health and Safety Advisory Committee
      • Member, ARPANSA’s Clinical Advisory Group

     

     

     

  • Professor Dorothy Keefe - Professor of Cancer Medicine, University of Adelaide; Medical Oncologist, Royal Adelaide Hospital Cancer Centre; and Clinical Ambassador, Transforming Health, SA Health

    Professor Keefe is Professor of Cancer Medicine at the University of Adelaide, a practising Medical Oncologist at the Royal Adelaide Hospital, and the Clinical Ambassador for Transforming Health in South Australia. She sits on the Cancer Australia Advisory Council, and on the Boards of BCNA (Breast Cancer Network of Australia) and MASCC (the Multinational Association of Supportive Care in Cancer). She is an expert in the toxicity of cancer treatment, and its management. She heads a research group at the University of Adelaide that studies toxicity of chemotherapy, radiotherapy and targeted anti-cancer agents, and has published widely in this field.

     

  • Professor Daniel Roos – Senior Radiation Oncologist, Royal Adelaide Hospital; Professor, School of Medicine, University of Adelaide

    Professor Roos is a practising Senior Radiation Oncologist at the Royal Adelaide Hospital and a Professor at the University of Adelaide’s School of Medicine. He is a Fellow of the Royal Australian and New Zealand College of Radiologists (RANZCR), a member of the RANZCR Australasian Palliative Radiation Oncology Group (APROG), a member of the International Lymphoma Radiation Oncology Group (ILROG) Council and the Regional Leader of the Society for Palliative Radiation Oncology (SPRO). He is a reviewer for many medical journals such as the International Journal of Radiation Oncology Biology and Physics, Radiotherapy and Oncology, Acta Oncologica and Clinical Oncology (Royal College of Radiologists). Professor Roos is also an Associate Editor for the Journal of Medical Imaging and Radiation Oncology. In 2011 he was awarded the Outstanding Contribution Award for the Trans-Tasman Radiation Oncology Group, and in 2015 received an Outstanding Reviewer Award, Radiotherapy and Oncology.

     

  • Dr Leanna Read – Chief Scientist for SA

    Dr Leanna Read is the fourth Chief Scientist for South Australia and a renowned biotechnology expert.

    Dr Read is currently the chair of the Cooperative Research Centre for Cell Therapy Manufacturing and member of the SA Economic Development Board, the Council for the University of South Australia and a member of BioAngels, which supports early-stage life sciences businesses.

    Dr Read is a Fellow of the Australian Academy of Technological Sciences and Engineering and Board Director of Biosensis Pty Ltd. She has led a number of successful research and commercial ventures, including the Cooperative Research Centre for Tissue Growth and Repair. She was also the founding Managing Director and CEO of Adelaide biotechnology company, TGR BioSciences from 2001 – 2012.

    A physiologist by training, Dr Read has published over 90 scientific papers and been awarded an Honorary Doctorate from the University of South Australia. She has received a number of awards, including the 2006 South Australian of the Year (Science and Technology) and the 2011 Central Region winner of the Ernst & Young Entrepreneur of the Year in the Technology Category.

    Current potentially relevant activities:

    • Chief Scientist for South Australia
    • Member of the NFCRC Expert Advisory Committee